NICE propose to charge £142,000 to conduct single technology appraisals from May 2017.
Read more HERE
Objectives: In March 2025, NICE adopted new HST routing criteria for evaluating technolo...
Read moreNICE’s Highly Specialised Technologies (HST) Programme offers a vital route for bringing ultra-rar...
Read moreBe the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.
Get in touchUS Most Favoured Nation (MFN) policy continues to evolve.
Join our complimentary 30-minute Office Hours session to explore the latest developments and what they could mean for pricing, launch sequencing and global strategy.
Hosted by Paul Craddy & Nicole Lodowski
